Global & Regional Health Technology Assessment

Scope & Guideline

Navigating the future of health technology together.

Introduction

Delve into the academic richness of Global & Regional Health Technology Assessment with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageMulti-Language
ISSN2284-2403
PublisherABOUTSCIENCE SRL
Support Open AccessYes
Country-
TypeJournal
Convergefrom 2014 to 2016, from 2019 to 2024
AbbreviationGLOB REG HEALTH TECH / Glob. Reg. Health Technol. Assess.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPIAZZA DUCA D AOSTA, 12, MILAN, MI 20124, ITALY

Aims and Scopes

The journal 'Global & Regional Health Technology Assessment' focuses on the evaluation of health technologies and their impact on health systems, particularly in the context of global and regional healthcare settings. It emphasizes the economic, clinical, and social aspects of health technology assessment (HTA) to inform policy and practice.
  1. Health Technology Evaluation:
    The journal aims to provide comprehensive evaluations of various health technologies, including pharmaceuticals, medical devices, and diagnostic tools, focusing on their clinical efficacy, safety, and cost-effectiveness.
  2. Economic Impact Analysis:
    It emphasizes the importance of economic evaluations, including cost-effectiveness and budget impact analyses, to assess the financial implications of health interventions on healthcare systems.
  3. Real-World Evidence:
    The journal prioritizes studies that utilize real-world data to evaluate health technologies, thereby informing clinical practice and healthcare decision-making with practical insights.
  4. Policy Recommendations:
    It aims to influence health policy by providing evidence-based recommendations for the pricing, reimbursement, and regulation of health technologies.
  5. Patient-Centered Outcomes:
    The journal also focuses on the assessment of patient-reported outcomes and their significance in evaluating the impact of health technologies on patient quality of life.
Recent trends in the journal's publications show a clear movement towards specific themes that are gaining traction. This section outlines the emerging topics that reflect the evolving landscape of health technology assessment.
  1. Patient-Centered Approaches:
    There is an increasing emphasis on incorporating patient-reported outcomes and experiences into health technology assessments, reflecting a broader trend towards patient-centered care.
  2. Real-World Data Utilization:
    The use of real-world data for evaluating the effectiveness and economic impact of health technologies is becoming more prevalent, indicating a shift towards evidence that reflects actual clinical practice.
  3. Innovative Pricing and Reimbursement Models:
    Emerging discussions around innovative pricing strategies and reimbursement models for new therapies highlight the need for adaptive approaches in light of evolving healthcare landscapes.
  4. Impact of COVID-19 on HTA:
    The journal is increasingly addressing the implications of the COVID-19 pandemic on health technology assessments, including changes in regulatory processes and the prioritization of certain health technologies.
  5. Multicriteria Decision Analysis (MCDA):
    The application of multicriteria decision analysis in health technology assessment is gaining attention, providing a structured approach to evaluate complex decisions involving multiple stakeholders.

Declining or Waning

While the journal has a broad and dynamic scope, certain themes have seen a decline in prominence over the recent years. This section highlights those areas that appear to be less frequently addressed in recent publications.
  1. Traditional Clinical Trials:
    There is a noticeable decline in the focus on traditional randomized controlled trials as the primary method for evaluating health technologies, with a growing preference for real-world evidence.
  2. General Health Economics:
    The broader field of health economics, while still relevant, seems to be overshadowed by more focused analyses such as cost-effectiveness and budget impact specific to particular diseases or therapies.
  3. Regulatory Frameworks:
    Discussions centered around the regulatory frameworks for HTA processes have decreased, indicating a potential shift towards more practical applications and outcomes of HTA rather than the processes themselves.

Similar Journals

Applied Health Economics and Health Policy

Shaping health policy with evidence-based economic insights.
Publisher: SPRINGER INT PUBL AGISSN: 1175-5652Frequency: 6 issues/year

Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.

Journal of Health Economics and Outcomes Research

Advancing health policy through innovative research.
Publisher: COLUMBIA DATA ANALYTICS, LLCISSN: 2327-2236Frequency: 1 issue/year

Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.

Expert Review of Pharmacoeconomics & Outcomes Research

Elevating Standards in Pharmacoeconomic Research
Publisher: TAYLOR & FRANCIS LTDISSN: 1473-7167Frequency: 6 issues/year

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.

BMC HEALTH SERVICES RESEARCH

Exploring the nexus of health policy and practice.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Health Services Research is a leading open-access journal dedicated to advancing the field of health policy and services research. Published by BMC since 2001 and based in the United Kingdom, this journal has established itself as an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of health care systems and policies. With an impressive 2023 Q1 ranking in the Health Policy category and a Scopus rank of 90/310, it clearly demonstrates its commitment to high-quality, impactful research. The journal's open-access model ensures that research findings are accessible to a global audience, promoting collaboration and innovation in health services. Spanning from 2001 to 2024, BMC Health Services Research is poised to remain at the forefront of health services research, making significant contributions to policy formulation and practice improvement in the healthcare sector.

Health Policy OPEN

Championing innovation in health policy for a healthier future.
Publisher: ELSEVIERISSN: Frequency: 1 issue/year

Health Policy OPEN is an esteemed open-access journal published by Elsevier that has made significant contributions to the field of health policy since its inception in 2020. With an impact factor placing it in the prestigious Q2 category of health policy journals, it ranks 116 out of 310 within the Scopus database, highlighting its critical engagement in the field and situating it within the 62nd percentile. As an open-access platform, Health Policy OPEN promotes the dissemination of high-quality research, making it accessible to a global audience of researchers, professionals, and students alike. The journal focuses on topical issues, innovative approaches, and evidence-based practices that shape health policies worldwide. With its headquarters in Amsterdam, Netherlands, the journal serves as a vital resource for advancing knowledge and fostering discussions that drive health policy initiatives and reforms. Engage with Health Policy OPEN to contribute to the evolving landscape of health policy and to stay informed on the latest research advancements.

MDM Policy & Practice

Advancing Health Policy Through Open Access Insights
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

MDM Policy & Practice is a premier open-access journal published by SAGE Publications Inc, focusing on the critical fields of Health Policy and Public Health, Environmental and Occupational Health. Since its inception in 2016, this journal has aimed to provide an authoritative platform for disseminating research findings, policy discussions, and innovative practices that drive improvements in health systems globally. With an impact factor that reflects its growing influence in the academic landscape, it holds a Q2 ranking in both Health Policy and Public Health categories as of 2023. This journal leverages its accessibility to foster a collaborative environment for researchers, policymakers, and practitioners alike, encouraging the exchange of ideas and knowledge to address pressing health challenges. Operating under a commitment to open access, MDM Policy & Practice ensures that vital research is available to a wider audience, fostering informed decision-making and progressive advancements in the health policy sphere.

VALUE IN HEALTH

Empowering Decision-Makers with Cutting-Edge Health Research
Publisher: ELSEVIER SCIENCE INCISSN: 1098-3015Frequency: 12 issues/year

VALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.

MEDICAL DECISION MAKING

Advancing health policy through rigorous research.
Publisher: SAGE PUBLICATIONS INCISSN: 0272-989XFrequency: 8 issues/year

Medical Decision Making is a premier journal published by SAGE Publications Inc, dedicated to advancing the field of health policy through rigorous research, innovative methodologies, and comprehensive analyses. Since its inception in 1981, it has established itself as a leading platform for disseminating significant findings, and it proudly holds a Q1 ranking in the health policy category, underscoring its commitment to excellence within the academic community. With an impressive Scopus rank of 43 out of 310, the journal ranks in the top 14% of its field, reflecting its influential contributions to medical decision-making processes. Medical Decision Making serves a diverse audience of researchers, practitioners, and policymakers by providing scholarly articles that blend theoretical insights with practical applications, ultimately improving patient care and health outcomes. The journal's dedicated following and its continued relevance through to 2024 position it as an essential resource for anyone vested in the evolution and implementation of effective health policies.

Pharmacoeconomics-Open

Transforming Healthcare Through Collaborative Scholarship
Publisher: SPRINGER INT PUBL AGISSN: 2509-4262Frequency: 4 issues/year

Pharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.

European Journal of Health Economics

Empowering Research in Health Economics and Policy
Publisher: SPRINGERISSN: 1618-7598Frequency: 4 issues/year

The European Journal of Health Economics, published by SPRINGER, is a premier interdisciplinary journal dedicated to advancing research in the intersection of health policy and economic theory. With an impressive impact factor and consistently ranked in the Q1 category in both Economics and Health Policy (2023), this journal serves as a vital platform for disseminating innovative research findings and practical insights relevant to today's healthcare challenges. Covering a broad spectrum of topics, from health care financing and economic evaluation to policy analysis, the journal aims to foster dialogue among academics, policymakers, and practitioners alike. Published continuously from 2002 to 2024, the European Journal of Health Economics holds its rank within the top 12% of Economics and Finance journals and the top 16% in Medicine. Researchers and students looking to stay abreast of the latest trends and methodologies in health economics will find this journal an invaluable resource.